Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Find generic entry opportunities
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Abstract:||The invention relates to a synergistic antimalarial composition which comprises the antimalarial agent benflumetol and also an antimalarial agent from the artemisinine group such as artemether. The composition can be formulated into solid dosage forms such as tablets and is useful for the treatment of drug resistant malaria.|
|Inventor(s):||Zhou; Yiqing (Beijing, CN), Ning; Dianxi (Beijing, CN), Wang; Shufen (Beijing, CN), Ding; Deben (Beijing, CN), Li; Guofu (Beijing, CN), Shan; Chengqi (Beijing, CN), Liu; Guangyu (Beijing, CN)|
|Assignee:||Ciba-Geigy AG (Basel, CH) Institute of Microbiology and Epidemiology, Academy of Military Medical (Beijing, CN)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Delivery; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||231||<disabled in preview>|
|African Regional IP Organization (ARIPO)||9100275||<disabled in preview>|
|Austria||135209||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.